Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

Development of therapeutic agents for severe acute respiratory syndrome (SARS) viral infection using short interfering RNA (siRNA) inhibitors exemplifies a powerful new means to combat emerging infectious diseases. Potent siRNA inhibitors of SARS coronavirus (SCV) in vitro were further evaluated for...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bao-jian, Tang, Qingquan, Cheng, Du, Qin, Chuan, Xie, Frank Y, Wei, Qiang, Xu, Jun, Liu, Yijia, Zheng, Bo-jian, Woodle, Martin C, Zhong, Nanshan, Lu, Patrick Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095788/
https://www.ncbi.nlm.nih.gov/pubmed/16116432
http://dx.doi.org/10.1038/nm1280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095788/
https://www.ncbi.nlm.nih.gov/pubmed/16116432
http://dx.doi.org/10.1038/nm1280

Ejemplares similares